Last update 16 Aug 2025

OHM-581

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
OHM 581, OHM-581, OHM581
Target
BET x JAK2
Action
inhibitors
Mechanism
BET inhibitors(Bromodomain and extra terminal domain protein inhibitors), JAK2 inhibitors(Tyrosine-protein kinase JAK2 inhibitors), Epigenetic drug
Therapeutic Areas
NeoplasmsHemic and Lymphatic DiseasesOther Diseases
Active Indication-
Inactive Indication
Hematologic NeoplasmsMyelofibrosis
Originator Organization
Ohm Oncology, Inc.Ohm Oncology, Inc.
Active Organization-
Inactive Organization
Ohm Oncology, Inc.Ohm Oncology, Inc.
Laxai Life Sciences Pvt Ltd.
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with OHM-581
Login to view more data
100 Translational Medicine associated with OHM-581
Login to view more data
100 Patents (Medical) associated with OHM-581
Login to view more data
100 Deals associated with OHM-581
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hematologic NeoplasmsPreclinical
United States
Laxai Life Sciences Pvt Ltd.
01 Jul 2019
Hematologic NeoplasmsPreclinical
United States
Ohm Oncology, Inc.Ohm Oncology, Inc.
01 Jul 2019
MyelofibrosisPreclinical
United States
Laxai Life Sciences Pvt Ltd.
01 Jul 2019
MyelofibrosisPreclinical
United States
Ohm Oncology, Inc.Ohm Oncology, Inc.
01 Jul 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free